Amgen poaches Tony Hooper from Bristol-Myers Squibb

pharmafile | October 21, 2011 | Appointment | Medical Communications Amgen, BMS 

Amgen has appointed Tony Hooper as the new executive vice president of global commercial operations.

Hooper, 56, joins Amgen after 16 years at Bristol-Myers Squibb, where he was most recently senior vice president of commercial operations and president, US, Japan and Intercontinental.

In this role, Hooper will report to Robert Bradway, president and chief operating officer, and will be responsible for the company’s global commercial operations.

Advertisement

Bradway said: “As we continue to grow, Tony’s track record of delivering results and his passion for serving patients across the globe make him an outstanding addition to Amgen’s leadership team.”

Hooper said: “It’s a privilege to join Amgen, a Company well-known for scientific innovation and developing life-changing therapies for people with serious illnesses.

“I am looking forward to bringing my global commercial experience to Amgen as it moves to implement its strategic vision for growth and international expansion.”

Related Content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) …

Amgen opens new biomanufacturing facility in Ohio, US

Amgen has announced that it has opened a new manufacturing site in Central Ohio, US. …

Elekta and BMS partner for digital treatment for melanoma

Elekta and Bristol Myers Squibb have announced a pilot collaboration in which the companies plan …

The Gateway to Local Adoption Series

Latest content